(Q28281529)
Statements
Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis (English)
Zan Shen
Feng Lin
Yuan-Jue Sun
Da-Liu Min
Li-Na Tang
Ai-Na He
Identifiers
2 references